Skip to main content

Table 1 Patient demographic and clinical characteristics

From: Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study

Characteristic

All Patients

(N= 1709)

Spain

(N= 441)

France

(N= 150)

UK

(N= 342)

Norway

(N= 48)

Finland

(N= 162)

Germany

(N= 326)

Poland

(N= 240)

Age (years)

62.94 ± 10.58

63.21 ± 10.52

62.96 ± 10.06

62.80 ± 11.80

62.25 ± 9.57

61.74 ± 10.08

64.90 ± 10.21

60.93 ± 9.78

Female (%)

45.08

45.58

34.00

40.76

45.83

48.15

48.00

51.05

Current Smokers (%)

13.53

14.09

16.11

14.84

9.09

11.73

9.09

17.35

No Alcohol Use (%)

29.37

49.04

24.67

28.27

20.51

27.78

18.44

14.56

No Regular Physical Activity(%)

35.38

29.50

40.67

41.43

38.10

19.14

44.20

32.71

Physical Activity 3-5 Times/Week (%)

24.92

29.98

13.33

11.53

21.43

53.09

14.11

38.79

Body Mass Index (kg/m2)

31.7 ± 6.8

32.1 ± 7.5

31.0 ± 5.0

31.1 ± 6.9

30.8 ± 4.3

32.7 ± 5.6

31.6 ± 5.7

31.53 ± 8.3

Microvascular Events (%)

2.16

2.28

0.67

3.23

2.08

3.11

0.31

3.33

Cardiovascular Events (%)

26.39

18.68

26.00

30.79

22.92

25.47

25.39

38.25

Duration of T2DM (years)

7.84 ± 5.08

8.25 ± 5.13

8.43 ± 5.26

7.05 ± 4.95

8.19 ± 5.50

7.07 ± 3.95

9.15 ± 5.12

6.46 ± 5.03

HbA1c (%)*

7.06 ± 1.06

7.05 ± 1.20

7.00 ± 1.00

7.22 ± 1.07

7.31 ± 1.06

6.99 ± 1.05

7.02 ± 0.99

6.89 ± 0.88

Patients with HbA1c < 6.5% (%)

27.91

31.75

30.67

19.30

16.67

34.57

26.99

30.42

  1. *Refers to the most recent HbA1c measurement within the 12 months prior to visit
  2. Data are mean ± SD unless otherwise specified
  3. T2DM = type 2 diabetes mellitus; HbA1c = hemoglobin A1c